X @Forbes
Forbes·2025-07-03 07:00
New drugs take too long to get to market because of clinical trial bottlenecks. Two cancer doctors built AI-enabled tech to speed up the process. https://t.co/PHYF8D5Ubd https://t.co/PHYF8D5Ubd ...
New drugs take too long to get to market because of clinical trial bottlenecks. Two cancer doctors built AI-enabled tech to speed up the process. https://t.co/PHYF8D5Ubd https://t.co/PHYF8D5Ubd ...